Other featured articles
Multi-Year Medicare Physician Fee Freeze Threatens Access: Pair Relief With Reforms
With fees frozen, high inflation threatens access to care and has other consequences.
CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation
Individuals in underserved communities have to travel long distances, well beyond the 30-minute standard, to access clinical trial sites for Aduhelm.
During the Height of the Opioid Epidemic, the Out-of-Pocket Price of Naloxone Increased by Over 500%
A jump in the out-of-pocket price of naloxone has likely made the lifesaving drug too expensive for most uninsured Americans.
Comments on AHRQ Analysis of Requirements for Coverage with Evidence Development
Researchers submitted a comment letter on the Agency for Healthcare Research and Quality (AHRQ)’s analysis for the Center for Medicare and Medicaid Services (CMS)’s requirements for Coverage with Evidence Development (CED) study design.